diphenylamine has been researched along with Teratoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baek, S; Choi, H; Heo, YT; Kim, J; Kim, NH; Quan, X; Xu, YN | 1 |
Blouin, L; Durruthy-Durruthy, J; Hejna, M; Liu, Y; Percharde, M; Qi, LS; Qi, Z; Qin, H; Ramalho-Santos, M; Sebastiano, V; Song, JS; Wong, P; Wossidlo, M; Yu, J | 1 |
2 other study(ies) available for diphenylamine and Teratoma
Article | Year |
---|---|
CRISPR/Cas9 nuclease-mediated gene knock-in in bovine-induced pluripotent cells.
Topics: Animals; Animals, Genetically Modified; Benzamides; Blastocyst; Cattle; Cells, Cultured; CRISPR-Cas Systems; Diphenylamine; Fertilization in Vitro; Fibroblasts; Gene Knock-In Techniques; Genetic Engineering; Genetic Enhancement; Genetic Loci; Genetic Vectors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Homologous Recombination; Induced Pluripotent Stem Cells; Mice; Mice, SCID; Polymorphism, Restriction Fragment Length; Pyridines; Pyrimidines; Recombinant Fusion Proteins; Teratoma; Transcription Factors; Valproic Acid | 2015 |
YAP Induces Human Naive Pluripotency.
Topics: Adaptor Proteins, Signal Transducing; Benzamides; Blastocyst; Cell Differentiation; Cells, Cultured; CRISPR-Cas Systems; Diphenylamine; Embryonic Stem Cells; Female; Gene Expression Regulation; Glycogen Synthase Kinase 3; Heterochromatin; Humans; Induced Pluripotent Stem Cells; Karyotype; Lysophospholipids; Male; Phosphoproteins; Pluripotent Stem Cells; Pyridines; Pyrimidines; RNA Interference; Teratoma; Transcription Factors; Wnt Signaling Pathway; YAP-Signaling Proteins | 2016 |